<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.04260.009</object-id><label>Table 1.</label><caption><p>Clinical presentation of A10 cKO, littermate control and <italic>tg</italic>a<italic>20</italic> mice inoculated with RML prions</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04260.009">http://dx.doi.org/10.7554/eLife.04260.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">RML prions</th><th colspan="2">CD1 mock</th></tr><tr><th>Clinical manifestations</th><th>A10 cKO (n = 7)</th><th>Controls (n = 8)</th><th><italic>tg</italic>a20 (n = 8)</th><th>A10 cKO (n = 5)</th><th>Controls (n = 11)</th></tr></thead><tbody><tr><td>First clinical signs (dpi)</td><td>68 (&#177;3.5)</td><td>106 (&#177;2.5)</td><td>n.a.</td><td>None</td><td>None</td></tr><tr><td>Duration of clinical signs (d)</td><td>35 (&#177;3.8)</td><td>40 (&#177;2.4)</td><td>n.a.</td><td>-</td><td>-</td></tr><tr><td>Time to terminal disease (dpi)</td><td>103 (&#177;6.6)</td><td>146 (&#177;2.1)</td><td>62 (&#177;2.8)</td><td>*</td><td>*</td></tr><tr><td>Progression of signs</td><td>Steady</td><td>Steady</td><td>Rapid</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Quitting of nest-building</td><td>All</td><td>All</td><td>All</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Ungroomed coat</td><td>Most (6/7)</td><td>Most (6/8)</td><td>Rare (2/8)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Stiff tail</td><td>All</td><td>Most (7/8)</td><td>Most (5/8)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Gait disturbance</td><td>All</td><td>All</td><td>All</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hind leg paresis</td><td>Rare (2/7)</td><td>Rare (3/8)</td><td>Most (7/8)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Kyphosis</td><td>Most (6/7)</td><td>Most (6/8)</td><td>Rare (3/8)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Weight loss</td><td>All</td><td>All</td><td>Most (6/8)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Late hypoactivity</td><td>All</td><td>All</td><td>Most (5/8)</td><td>&#8211;</td><td>&#8211;</td></tr></tbody></table><table-wrap-foot><fn><p>Negative controls included A10 cKO and littermate controls inoculated with CD1 brain homogenates (mock). Asterisks indicate that CD1 mock-inoculated animals were sacrificed at 200 days post inoculation (dpi) without any clinical signs.</p></fn></table-wrap-foot></table-wrap>